Avance Clinical To Showcase Asia-Pacific Clinical Trial Expertise At BIO Korea 2025
Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, will attend BIO Korea 2025 to meet with biotechs and share clinical trial capabilities across the region including Australia, New Zealand, South Korea, Taiwan, North America and beyond.
The conference is scheduled from May 7 to 9 2025, at COEX in Seoul. This year marks the 20th edition of BIO KOREA, which is recognized as Korea’s largest international life sciences convention, organized by the Korea Health Industry Development Institute (KHIDI).
Avance Clinical’s Director, Asian Operations, Jessica Han; Associate Director, Operations Taiwan, Kelly Yang; SE Asia, Scientific and Regulatory Affairs Senior Specialist, Hee NamGung; Associate Director, Business Development, James Lumicisi; and Director of Strategic Partnerships, Robert Jones, will be attending and available for partnering meetings at BIO KOREA 2025.
Jessica Han, based in Seoul, brings over 18 years of experience in healthcare and clinical research. As Director of Asian Operations, her leadership is instrumental in driving Avance Clinical’s regional strategy and operational excellence across Asia.
Kelly Yang, with over 15 years in the pharmaceutical and clinical research industries, leads Avance Clinical’s operations in Taiwan. Her strong background in clinical operations and project management reinforces our capabilities and local execution in the region.
Recently, Avance Clinical formalized strategic partnerships with leading Korean institutions, including CHA University Bundang Medical Center, Korea University Medicine, and Dong-A University Hospital. These Memorandums of Understanding (MOUs) strengthen Avance Clinical’s capacity to offer flexible and high-quality clinical trial services across the Asia-Pacific region.
Jessica Han said, “Avance Clinical’s participation in BIO KOREA 2025 underscores our commitment to advancing clinical research in South Korea and across the broader Asia region. We look forward to meaningful engagement with industry leaders and uncovering new opportunities to drive innovation and growth in the bio-health sector.”
Avance Clinical offers a seamless solution for biotechs looking for a CRO partner with deep experience in regulatory strategy and site relationships across Asia, North America, Australia and New Zealand. Clients benefit from rapid start-up and patient recruitment, with global quality data accepted by all major regulatory authorities including the FDA and EMA. The Asia-Pacific region is increasingly attractive due to the patient recruitment advantages, high-quality data, and advanced medical infrastructure in countries such as South Korea.
The team will be at Booth B1 during the event.
About Avance Clinical
Avance Clinical is a leading Contract Research Organization (CRO) offering biotech companies faster, more flexible, and higher-quality clinical trial services. As the largest premium full-service CRO headquartered in Australia, Avance Clinical delivers globally accepted data across Australia, New Zealand, Asia, North America, and Europe for international biotechs. With 30 years of experience and expertise spanning over 250 indications, the company provides comprehensive clinical research services from early to late-phase trials.
- Discover Avance Clinical’s Australian Advantage and Asia Advantage
- Get into clinic faster with Avance Clinical’s ClinicReady service
- Learn about Avance Clinical’s GlobalReady model for biotechs
- Speak with our clinical trial experts about your upcoming study
- Book a meeting or request a proposal